Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

BoltzProt-1

AI overview

Sign in and the AI will write an overview from our coverage.

Headlines · 1

  1. Boltz raises $110M Series A for AI drug discovery

    London-based Boltz raised a $110 million Series A led by Bessemer Venture Partners, following a $28 million seed round in 2025. The company sells BoltzMol-1 and BoltzProt-1 through Boltz Lab and an API, offering molecular screening and protein design without operating its own drug pipeline. Boltz reported 50-fold growth in customer token consumption since June and said six of the 20 largest pharmaceutical companies were clients, though the supplied reports do not independently verify these usage and adoption figures.

    SiliconANGLE AI · 🔥 9

Experience and discussion from the community

Share my BoltzProt-1 experienceAsk about BoltzProt-1

Nobody has shared their experience with BoltzProt-1 yet.